Rolling Out14h
How sleep impacts your risk of developing diabetes
Sacrificing your sleep comes with significant risks, particularly concerning your blood sugar levels and the potential for ...
AOL1d
What is Sleep Apnea? Symptoms & Treatment Options
Other symptoms you or a partner may notice include: Obstructive sleep apnea (OSA). This is the most common type of sleep ...
Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
The gross proceeds to the Company from the offering are expected to be approximately $4.3 million, before deducting the placement agent's fees and other offering expenses payable by the Company. The ...
FDA Approval Sends Shares of this Healthcare Company Higher
What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...
bovnews3d
Vivos Therapeutics (VVOS) Surges Following Landmark FDA Approval
Vivos Therapeutics is a pioneering medical device and technology company focused on addressing sleep-related breathing disorders (SRBDs), particularly obstructive sleep apnea (OSA). Their flagship ...
ResMed slips as Wolfe downgrades on GLP-1 threat from Lilly
ResMed (RMD) stock falls as Wolfe downgrades due to potential label expansion for Eli Lilly's (LLY) tirzepatide in ...
Vivos surges on FDA nod for pediatric sleep apnea device
Vivos Therapeutics (VVOS) stock gains as company receives FDA clearance for its DNA appliance to treat obstructive sleep ...
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Awarded First-Ever FDA Clearance for Pediatric Treatment of Sleep Apnea, Snoring
Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
The FDA has granted 510(k) clearance to Vivos Therapeutics' DNA oral appliance for treating moderate to severe obstructive ...
Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring
Vivos is poised to disrupt the very significant pediatric obstructive sleep apnea (OSA) market with new FDA clearance and new strategic marketing ...
phelpscountyfocus4d
Phelps Health offers Inspire Therapy for Obstructive Sleep Apnea
Phelps Health offers Inspire® therapy, a breakthrough obstructive sleep apnea (OSA) treatment option for those who struggle ...